Krzysztof J Misiukiewicz, MD
- ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
- ASSISTANT PROFESSOR | Otolaryngology
- Cancer (Oncology)
- Hospital Affiliation
- The Mount Sinai Hospital
- Ruttenberg Treatment Center 212-241-6756 212-241-6756
Krzysztof Misiukiewicz, MD, is Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. A member of the faculty since 2009, Dr. Misiukiewicz has clinical expertise in the medical management of head and neck and thyroid cancers. He is Clinical Director of Research in Head and Neck, Clinical Director of the Center for Personalized Cancer Therapeutics (CPCT) at The Tisch Cancer Institute, and Chairman of the Oncology Pharmacy & Therapeutics Committee. Dr. Misiukiewicz is Principal Investigator of the key personalized clinical trials offered at CPCT; he holds a Master’s degree in clinical research.
Dr. Misiukiewicz investigates new ways to combine traditional treatments, such as chemotherapy and radiotherapy, with the latest targeted agents and immunotherapy in order to improve treatment results and decrease side effects in patients with head and neck and thyroid cancers. He is also working on identifying drugs that target the genetic changes of an individual’s tumor with an understanding of tumor genetic complexity.
Using a personalized medicine approach, Dr. Misiukiewicz offers patients a customized care plan tailored to their specific cancer and access to innovative treatments.
- Adenoid Cystic Carcinoma (ACC)
- Head and Neck Cancers
- Laryngeal Cancer
- Lymph Node Biopsy
- Nasal Cancer
- Nasal Cavity Cancer
- Nasopharyngeal Cancer (NPC)
- Oral Cavity Cancer
- Salivary Gland Tumors
- Sinus Cancer
- Skull Base Tumor/Cancer
- Throat Cancer
- Thyroid Cancer
- Tongue Cancer
- Tonsil Cancer
Residency, Internal Medicine
St. Barnabas Medical Center
Mount Sinai Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Misiukiewicz did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.